Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction

Boosting transcorneal permeability and pharmacological activity of drug poses a great challenge in the field of ocular drug delivery. In the present study, we propose a drug-peptide supramolecular hydrogel based on anti-inflammatory drug, dexamethasone (Dex), and Arg-Gly-Asp (RGD) motif for boosting...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lin Chen, Jie Deng, Ailing Yu, Yuhan Hu, Bo Jin, Pengyuan Du, Jianhong Zhou, Lei Lei, Yuan Wang, Serhii Vakal, Xingyi Li
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2022
Materias:
Acceso en línea:https://doaj.org/article/0ae567cf3ca14845872684223abbbabd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0ae567cf3ca14845872684223abbbabd
record_format dspace
spelling oai:doaj.org-article:0ae567cf3ca14845872684223abbbabd2021-11-28T04:35:30ZDrug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction2452-199X10.1016/j.bioactmat.2021.09.006https://doaj.org/article/0ae567cf3ca14845872684223abbbabd2022-04-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2452199X21004163https://doaj.org/toc/2452-199XBoosting transcorneal permeability and pharmacological activity of drug poses a great challenge in the field of ocular drug delivery. In the present study, we propose a drug-peptide supramolecular hydrogel based on anti-inflammatory drug, dexamethasone (Dex), and Arg-Gly-Asp (RGD) motif for boosting transcorneal permeability and pharmacological activity via the ligand-receptor interaction. The drug-peptide (Dex-SA-RGD/RGE) supramolecular hydrogel comprised of uniform nanotube architecture formed spontaneously in phosphate buffered saline (PBS, pH = 7.4) without external stimuli. Upon storage at 4 °C, 25 °C, and 37 °C for 70 days, Dex-SA-RGD in hydrogel did not undergo significant hydrolysis, suggesting great long-term stability. In comparison to Dex-SA-RGE, Dex-SA-RGD exhibited a more potent in vitro anti-inflammatory efficacy in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages via the inhibition of nuclear factor кB (NF-κB) signal pathway. More importantly, using drug-peptide supramolecular hydrogel labeled with 7-nitro-2,1,3-benzoxadiazole (NBD), the Dex-SA-K(NBD)RGD showed increased performance in terms of integrin targeting and cellular uptake compared to Dex-SA-K(NBD)RGE, as revealed by cellular uptake assay. On topical instillation in rabbit's eye, the proposed Dex-SA-K(NBD)RGD could effectively enhance the transcorneal distribution and permeability with respect to the Dex-SA-K(NBD)RGE. Overall, our findings demonstrate the performance of the ligand-receptor interaction for boosting transcorneal permeability and pharmacological activity of drug.Lin ChenJie DengAiling YuYuhan HuBo JinPengyuan DuJianhong ZhouLei LeiYuan WangSerhii VakalXingyi LiKeAi Communications Co., Ltd.articleActive transportIntegrinSupramolecular hydrogelOcular retentionCorneal permeabilityMaterials of engineering and construction. Mechanics of materialsTA401-492Biology (General)QH301-705.5ENBioactive Materials, Vol 10, Iss , Pp 420-429 (2022)
institution DOAJ
collection DOAJ
language EN
topic Active transport
Integrin
Supramolecular hydrogel
Ocular retention
Corneal permeability
Materials of engineering and construction. Mechanics of materials
TA401-492
Biology (General)
QH301-705.5
spellingShingle Active transport
Integrin
Supramolecular hydrogel
Ocular retention
Corneal permeability
Materials of engineering and construction. Mechanics of materials
TA401-492
Biology (General)
QH301-705.5
Lin Chen
Jie Deng
Ailing Yu
Yuhan Hu
Bo Jin
Pengyuan Du
Jianhong Zhou
Lei Lei
Yuan Wang
Serhii Vakal
Xingyi Li
Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction
description Boosting transcorneal permeability and pharmacological activity of drug poses a great challenge in the field of ocular drug delivery. In the present study, we propose a drug-peptide supramolecular hydrogel based on anti-inflammatory drug, dexamethasone (Dex), and Arg-Gly-Asp (RGD) motif for boosting transcorneal permeability and pharmacological activity via the ligand-receptor interaction. The drug-peptide (Dex-SA-RGD/RGE) supramolecular hydrogel comprised of uniform nanotube architecture formed spontaneously in phosphate buffered saline (PBS, pH = 7.4) without external stimuli. Upon storage at 4 °C, 25 °C, and 37 °C for 70 days, Dex-SA-RGD in hydrogel did not undergo significant hydrolysis, suggesting great long-term stability. In comparison to Dex-SA-RGE, Dex-SA-RGD exhibited a more potent in vitro anti-inflammatory efficacy in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages via the inhibition of nuclear factor кB (NF-κB) signal pathway. More importantly, using drug-peptide supramolecular hydrogel labeled with 7-nitro-2,1,3-benzoxadiazole (NBD), the Dex-SA-K(NBD)RGD showed increased performance in terms of integrin targeting and cellular uptake compared to Dex-SA-K(NBD)RGE, as revealed by cellular uptake assay. On topical instillation in rabbit's eye, the proposed Dex-SA-K(NBD)RGD could effectively enhance the transcorneal distribution and permeability with respect to the Dex-SA-K(NBD)RGE. Overall, our findings demonstrate the performance of the ligand-receptor interaction for boosting transcorneal permeability and pharmacological activity of drug.
format article
author Lin Chen
Jie Deng
Ailing Yu
Yuhan Hu
Bo Jin
Pengyuan Du
Jianhong Zhou
Lei Lei
Yuan Wang
Serhii Vakal
Xingyi Li
author_facet Lin Chen
Jie Deng
Ailing Yu
Yuhan Hu
Bo Jin
Pengyuan Du
Jianhong Zhou
Lei Lei
Yuan Wang
Serhii Vakal
Xingyi Li
author_sort Lin Chen
title Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction
title_short Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction
title_full Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction
title_fullStr Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction
title_full_unstemmed Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction
title_sort drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction
publisher KeAi Communications Co., Ltd.
publishDate 2022
url https://doaj.org/article/0ae567cf3ca14845872684223abbbabd
work_keys_str_mv AT linchen drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
AT jiedeng drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
AT ailingyu drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
AT yuhanhu drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
AT bojin drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
AT pengyuandu drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
AT jianhongzhou drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
AT leilei drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
AT yuanwang drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
AT serhiivakal drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
AT xingyili drugpeptidesupramolecularhydrogelboostingtranscornealpermeabilityandpharmacologicalactivityvialigandreceptorinteraction
_version_ 1718408300414894080